0001415889-24-011395.txt : 20240423 0001415889-24-011395.hdr.sgml : 20240423 20240423193032 ACCESSION NUMBER: 0001415889-24-011395 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240414 FILED AS OF DATE: 20240423 DATE AS OF CHANGE: 20240423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harler Mary Beth CENTRAL INDEX KEY: 0002018699 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39045 FILM NUMBER: 24866359 MAIL ADDRESS: STREET 1: C/O IGM IOSCIENCES, INC. STREET 2: 325 E,. MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IGM Biosciences, Inc. CENTRAL INDEX KEY: 0001496323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770349194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 325 E MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-965-7873 MAIL ADDRESS: STREET 1: 325 E MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FORMER COMPANY: FORMER CONFORMED NAME: Palingen, Inc. DATE OF NAME CHANGE: 20100712 3 1 form3-04232024_110425.xml X0206 3 2024-04-14 0 0001496323 IGM Biosciences, Inc. IGMS 0002018699 Harler Mary Beth C/O IGM BIOSCIENCES, INC. 325 E. MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 false true false false Head, Research & Autoimmunity Common Stock 86797 D Stock Option (right to buy) 61.45 2031-10-11 Common Stock 200000 D Stock Option (right to buy) 17.11 2032-03-12 Common Stock 75000 D Stock Option (right to buy) 12.86 2033-04-04 Common Stock 52500 D Stock Option (right to buy) 9.95 2034-03-12 Common Stock 92500 D Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU. 1/4th of the shares subject to the option vested on October 11, 2022 and 1/48 of the shares subject to the option vest each month thereafter, provided that the Reporting Person remains a service provider through each vesting date. 1/48th of the shares subject to the option vested on April 12, 2022 and 1/48 of the shares subject to the option vest each month thereafter, provided that the Reporting Person remains a service provider through each vesting date. 1/48th of the shares subject to the option vested on April 12, 2023 and 1/48 of the shares subject to the option vest each month thereafter, provided that the Reporting Person remains a service provider through each vesting date. 1/48th of the shares subject to the option vested on April 12, 2024 and 1/48 of the shares subject to the option vest each month thereafter, provided that the Reporting Person remains a service provider through each vesting date. Exhibit 24 - Power of Attorney /s/ Misbah Tahir, by power of attorney 2024-04-23 EX-24 2 ex24-04232024_110427.htm ex24-04232024_110427.htm


POWER OF ATTORNEY


The undersigned, as a Section 16 reporting person of IGM Biosciences, Inc. (the “Company”),

hereby constitutes and appoints Fred Schwarzer and Misbah Tahir, and each of

them, as the undersigned’s true and lawful attorney-in-fact to:


1.

complete and execute Forms 3, 4 and 5 and other forms and all amendments thereto as

such attorney-in fact shall in his discretion determine to be required or advisable pursuant

to Section 16 of the Securities Exchange Act of 1934 (as amended) and the rules and

regulations promulgated thereunder, or any successor laws and regulations, as a

consequence of the undersigned’s ownership, acquisition or disposition of securities of

the Company; and


2.

do all acts necessary in order to file such forms with the Securities and Exchange

Commission, any securities exchange or national association, the Company and such

other person or agency as the attorneys-in-fact shall deem appropriate.


The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall

do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing

attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming,

nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section

16 of the Securities Exchange Act of 1934 (as amended). This Power of Attorney shall remain in

full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with

respect to the undersigned’s holdings of and transactions in securities issued by the Company,

unless earlier revoked by the undersigned in a signed writing delivered to the Company and the

foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed

as of this 4th day of April, 2024.

MARY BETH HARLER


/s/ Mary Beth Harler